Overview


According to FutureWise analysis the market for ai genomics in 2023 is US$ 0.5 billion, and is expected to reach US$ 4.76 billion by 2031 at a CAGR of 32.5%.

Artificial intelligence has emerged as a powerful platform for streamlining the analysis of complex genomic datasets and helping researchers explore the genetic basis of diseases or phenotypes through modern sequencing techniques. Genomics is the analysis of an organism's entire genome, which includes all of its genes and non-coding sequences of DNA. By utilizing AI techniques such as machine learning, deep learning, and other AI techniques, researchers and clinicians can extract an immense amount of genomic information available, leading to advancements in medicine, agriculture, evolutionary biology, and more. Furthermore, deep learning is becoming important for base calling within the genomic instrument using RNN- and convolutional neural network (CNN)-based models. Neural networks interpret image and signal data generated by devices and infer the 3 billion nucleotide pairs of the human genome. This improves the accuracy of the reads and ensures that base calling occurs closer to real-time, further hastening the entire genomics workflow, from sample to variant call format to final report.

Precision medicine is a growing field of therapeutics that is built on human genetic makeup, lifestyle, gene expression, and environment. The advancement of medical care has surpassed the conventional symptom-driven treatment process by enabling early risk prognosis of disease through enhanced diagnostics and tailoring more effective therapies. It is necessary to analyze overall patient data and other factors to observe and differentiate between ill and relatively healthy individuals to take the most appropriate path toward precision medicine. This results in an improved vision of biological markers that indicate changes in health. Integrating precision and genomic medicine with AI can improve patient healthcare.

FutureWise Market Research has published a report that provides an insightful AI genomics market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, AI genomics market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • IBM
  • Microsoft
  • NVIDIA Corporation
  • DeepGenomics
  • BenevolentAI
  • Fabric Genomics Inc.
  • Verge Genomics
  • Freenome Holdings Inc.
  • MolecularMatch Inc.
  • Cambridge Cancer Genomics
  • Sophia genetics
  • Data4Cure Inc.
  • PrecisionLife Ltd
  • Genoox Ltd
  • Lifebit
  • Diploid
  • FDNA Inc.
  • DNAnexus Inc.
  • Empiric Logic
  • Engine Biosciences Pte.Ltd

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Offering

  • Software
  • Services

By Technology

  • Machine Learning
    • Deep Learning
    • Supervised Learning
    • Reinforcement Learning
    • Unsupervised Learning
    • Other Machine Learning Technologies
  • Other Technologies

By Functionality

  • Genome Sequencing
  • Gene Editing
  • Clinical Workflows
  • Predicitive Genetic Testing and Preventive Medicine

By Application

  • Diagnostics
  • Drug Discovery and Development
  • Precision Medicine
  • Argriculture and Animal Research
  • Other Applications

By End-User

  • Pharmaceutical and Biotech Companies
  • Healthcare Providers
  • Research Centers
  • Academic Institutes
  • Governmnet Organisations
  • Other End-users

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the AI Genomics Market By Offering, By Technology, By Functionality, By Application, By End-User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   AI Genomics Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of AI Genomics Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   AI Genomics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   AI Genomics Market, By Offering Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Software
        2. Services

  • 8.   AI Genomics Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Machine learning
         1.1. Deep Learning
         1.2. Supervised Learning
         1.3. Reinforcement Learning
         1.4. Unsupervised Learning
         1.5. Other Machine Learning Technologies
        2. Other Technologies

  • 9.   AI Genomics Market, By Functionality Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Genome Sequencing
        2. Gene Editing
        3. Clinical Workflows
        4. Predicitive Genetic Testing and Preventive Medicine

  • 10.   AI Genomics Market, By Applications Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Diagnostics
        2. Drug Discovery and Development
        3. Precision medicine
        4. Argriculture and Animal Research
        5. Other Applications

  • 11.   AI Genomics Market, By End-User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Pharmaceutical and Biotech Companies
        2. Healthcare Providers
        3. Research Centers
        4. Academic Institutes
        5. overnmnet Organisations
        6. Other End-users

  • 12.   North America AI Genomics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America AI Genomics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe AI Genomics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific AI Genomics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. IBM
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Microsoft
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. NVIDIA Corporation
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. DeepGenomics
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. BenevolentAI
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Fabric Genomics Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Verge Genomics
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Freenome Holdings Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. MolecularMatch Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Cambridge Cancer Genomics
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Sophia Genetics
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Data4Cure Inc.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. PrecisionLife Ltd
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Genoox Ltd.
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Lifebit
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Diploid
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
            16.4. Financial Overview
         16.5. Strategic Overview
        17. FDNA Inc.
         17.1. Company Overview
         17.2. Product Portfolio
            17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. DNAnexus Inc.
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
          19. Empiric Logic
            19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20. Engine Biosciences Pte.Ltd
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 20.   FutureWise SME Key Takeaway Points for Client

Related Market

Genomics Market

Read More

Consumer Genomics Market

Read More

Metagenomics Market

Read More
Partner

Our Clients